Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed

资助机构

National Institutes of Health (NIH)

Department of Health and Human Services (HHS)

地区

United States

研究领域

Health

截止日期

Jun 06, 2025 12:00:00 AM EDT

基金规模

$295,924

联系方式

National Institutes of Health Grantsinfo@nih.gov

申请资格

Eligible Applicants:

Small businesses

Additional Information on Eligibility:

Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
See full Notice of Funding Opportunity for additional details on eligibility.

基金编号

PAR-23-268

说明

This FOA provides support using the STTR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated the ability for specific and targeted tissue and organ repair, which can be harnessed for applications such as extracellular vesicle-based therapeutics. The main objective for this funding opportunity is to support platform-oriented technology development associated with the production, manufacturing, and use, of extracellular vesicles as therapeutics in regenerative medicine.

网站

http://grants.nih.gov/grants/guide/pa-files/PAR-23-268.html

基金资源
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接